Pfizer to buy Allergan in $160 billion deal: Reuters
Pfizer Inc, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan Plc in a transaction valued at about $160 billion, Reuters News reported.
23 November 2015•2 mins read
Pfizer Inc, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan Plc in a transaction valued at about $160 billion, Reuters News reported.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
18 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
18 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
19 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
19 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
19 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
19 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
21 hours ago · 3 mins read
